Therapeutic Potential of Senolytics in Cardiovascular Disease.
Therapeutic Potential of Senolytics in Cardiovascular Disease.
复制标题
DOI:
10.1007/s10557-020-07075-w
复制
发表时间:
2022-03
影响因子:
3.4
通讯作者:
Richardson GD
中科院分区:
文献类型:
--
作者:
Dookun E;Passos JF;Arthur HM;Richardson GD
Ageing is the biggest risk factor for impaired cardiovascular health, with cardiovascular disease being the leading cause of death in 40% of individuals over 65 years old. Ageing is associated with both an increased prevalence of cardiovascular disease including heart failure, coronary artery disease, and myocardial infarction. Furthermore, ageing is associated with a poorer prognosis to these diseases. Genetic models allowing the elimination of senescent cells revealed that an accumulation of senescence contributes to the pathophysiology of cardiovascular ageing and promotes the progression of cardiovascular disease through the expression of a proinflammatory and profibrotic senescence-associated secretory phenotype. These studies have resulted in an effort to identify pharmacological therapeutics that enable the specific elimination of senescent cells through apoptosis induction. These senescent cell apoptosis-inducing compounds are termed senolytics and their potential to ameliorate age-associated cardiovascular disease is the focus of this review.
登录
查看更多内容
影响因子:
7.8
作者:
Bernardes de Jesus B;Schneeberger K;Vera E;Tejera A;Harley CB;Blasco MA
通讯作者:
Blasco MA
影响因子:
64.8
作者:
Baker DJ;Childs BG;Durik M;Wijers ME;Sieben CJ;Zhong J;Saltness RA;Jeganathan KB;Verzosa GC;Pezeshki A;Khazaie K;Miller JD;van Deursen JM
通讯作者:
van Deursen JM
DOI:
10.1146/annurev-pathol-121808-102144
发表时间:
2010
期刊:
Annual review of pathology
影响因子:
--
作者:
Coppé JP;Desprez PY;Krtolica A;Campisi J
通讯作者:
Campisi J
影响因子:
82.9
作者:
Ait-Oufella, H;Salomon, BL;Mallat, Z
通讯作者:
Mallat, Z
影响因子:
2.8
作者:
Bruening, Ansgar
通讯作者:
Bruening, Ansgar